Quantum Biopharma (QNTM) Q3 2024 Earnings
QNTM·Reported August 14, 2024·Before market open
Diluted EPS came in at $-5.20, missed the $-3.90 consensus by $1.30.
Diluted EPS
$-5.20missed by $1.30
Consensus: $-3.90
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about Quantum Biopharma's Q3 2024 earnings report.
Quantum Biopharma (QNTM) reported Q3 2024 earnings on August 14, 2024 before market open.
Quantum Biopharma reported diluted EPS of $-5.20 for Q3 2024.
EPS missed the consensus estimate of $-3.90 by $1.30.